Trials / Completed
CompletedNCT01254318
Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)
Temporal Realistic Assessment of the Fungal Infection Incidence Across Canada for High Risk Subjects With Hematological Disease (TRAFIC)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This will be a retrospective study that includes retrospective chart reviews at major institutions across Canada. The intent of the study is to generate both regional and national incidence data for non-Candida invasive fungal infections (IFI) in high risk participants. The study will include participants receiving stem cell transplant and high dose chemotherapy treatment for leukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard Care | Health-care interventions will be recorded; no additional procedures outside the standard of care will be required. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2010-12-06
- Last updated
- 2016-11-02
- Results posted
- 2016-11-02
Source: ClinicalTrials.gov record NCT01254318. Inclusion in this directory is not an endorsement.